Taken together, these results demonstrate the potential for combined IAP and WEE1 inhibition to exert anti-cancer activity and sensitize HNSCC cells to TNFα-induced cytotoxicity. The gene discussed is WEE1; the disease is head and neck squamous cell carcinoma.